Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HUMSCs Combined With Bovine Type I Collagen for Third-Degree Burn Wounds
NCT07530003Phase 2Recruiting
- Sponsor
- Xinxiang Medical University First Affiliated Hospital
- Start
- Apr 2026
- Primary completion
- Dec 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in Third-degree burn, sponsored by Xinxiang Medical University First Affiliated Hospital. Started Apr 2026; status: recruiting.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
Third-degree burn
Beyond the preview
Go deeper on NCT07530003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07530003.